Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of the glycosylation of one or more amino acid residues within a protein. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins. [GOC:dms, GOC:dph, GOC:pr]
Positive regulation of protein glycosylation is a complex process involving a series of steps that are tightly regulated to ensure the proper synthesis, modification, and function of glycoproteins. These steps include:
**1. Synthesis of Glycosyl Donor Substrates:** The process begins with the synthesis of sugar nucleotides, such as UDP-glucose, GDP-mannose, and CMP-sialic acid, which serve as donor substrates for glycosylation. These substrates are generated through metabolic pathways involving specific enzymes.
**2. Assembly of Oligosaccharide Precursors:** Once the glycosyl donor substrates are available, oligosaccharide precursors are assembled in the endoplasmic reticulum (ER) through a series of enzymatic reactions. These precursors are typically branched structures composed of various sugar residues.
**3. Protein Folding and Glycosylation Initiation:** As newly synthesized proteins enter the ER, they undergo folding and initial glycosylation events. This involves the addition of specific sugar residues to the protein backbone, often through the action of glycosyltransferases.
**4. Protein Trafficking and Further Glycosylation:** After initial glycosylation, glycoproteins are transported through the ER and Golgi apparatus. During this transit, they undergo further modifications, including the addition of more complex sugar chains, the removal of specific sugar residues, and the branching of oligosaccharide structures.
**5. Regulation of Glycosyltransferase Activity:** The activity of glycosyltransferases is tightly regulated by various factors, including:
* **Protein Kinases and Phosphatases:** These enzymes can phosphorylate or dephosphorylate glycosyltransferases, thereby modulating their activity.
* **Chaperone Proteins:** Chaperones assist in the correct folding of glycosyltransferases and ensure their proper localization within the ER and Golgi.
* **Transcriptional and Post-Transcriptional Regulation:** The expression levels of glycosyltransferases can be controlled at the level of gene transcription or mRNA translation.
**6. Quality Control Mechanisms:** The ER and Golgi contain quality control mechanisms that monitor the proper folding and glycosylation of glycoproteins. If defects are detected, the glycoproteins may be retained in these compartments or targeted for degradation.
**7. Final Glycosylation and Protein Sorting:** In the trans-Golgi network, glycoproteins undergo final glycosylation modifications and are sorted to their appropriate destinations, such as the plasma membrane, lysosomes, or secretory vesicles.
**8. Biological Function of Glycoproteins:** Glycosylation plays a crucial role in determining the biological function of glycoproteins. Glycans can:
* **Influence Protein Folding and Stability:** Glycosylation can contribute to the proper folding and stability of proteins.
* **Mediate Protein-Protein Interactions:** Glycans can serve as recognition sites for other proteins, thereby mediating interactions between different molecules.
* **Protect Proteins from Degradation:** Glycosylation can shield proteins from proteolytic degradation.
* **Influence Protein Localization:** Glycans can direct proteins to specific cellular compartments.
* **Modify Protein Activity:** Glycosylation can modulate the activity of proteins by altering their conformation or interactions with other molecules.
**9. Dysregulation of Glycosylation and Disease:** Dysregulation of glycosylation processes is implicated in various diseases, including cancer, inflammatory disorders, and genetic disorders. Aberrant glycosylation patterns can disrupt protein function, alter cell signaling pathways, and contribute to disease development.
Positive regulation of protein glycosylation is essential for the proper functioning of cells and organisms. Dysregulation of this process can have significant consequences for health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Receptor activity-modifying protein 1 | A receptor activity-modifying protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60894] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
telcagepant | telcagepant: structure in first source | ||
mk 3207 | |||
mk-8825 | |||
atogepant | atogepant : A secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine. | azaspiro compound; organic heterotetracyclic compound; piperidones; secondary carboxamide; trifluorobenzene | calcitonin gene-related peptide receptor antagonist |